TD Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$275M Buy
2,288,576
+57,755
+3% +$6.67M 0.22% 85
2025
Q4
$235M Buy
2,230,821
+152,026
+7% +$14.3M 0.19% 102
2025
Q3
$174M Buy
2,078,795
+87,543
+4% +$7.21M 0.14% 136
2025
Q2
$158M Sell
1,991,252
-240,683
-11% -$19.1M 0.13% 148
2025
Q1
$200M Sell
2,231,935
-152,254
-6% -$14.2M 0.18% 117
2024
Q4
$237M Sell
2,384,189
-122,358
-5% -$12.6M 0.21% 105
2024
Q3
$285M Sell
2,506,547
-2,683,806
-52% -$319M 0.25% 85
2024
Q2
$643M Buy
5,190,353
+25,038
+0.5% +$3.23M 0.6% 33
2024
Q1
$682M Sell
5,165,315
-222,509
-4% -$27.4M 0.63% 31
2023
Q4
$587M Buy
5,387,824
+360,688
+7% +$37.4M 0.58% 36
2023
Q3
$518M Buy
5,027,136
+74,194
+1% +$8M 0.63% 35
2023
Q2
$572M Buy
4,952,942
+86,356
+2% +$9.8M 0.65% 31
2023
Q1
$518M Buy
4,866,586
+2,374,338
+95% +$256M 0.62% 34
2022
Q4
$277M Sell
2,492,248
-143,556
-5% -$14.7M 0.34% 61
2022
Q3
$228M Sell
2,635,804
-191,234
-7% -$17.1M 0.29% 68
2022
Q2
$258M Sell
2,827,038
-113,490
-4% -$10.1M 0.3% 68
2022
Q1
$241M Sell
2,940,528
-192,058
-6% -$15.1M 0.22% 90
2021
Q4
$240M Sell
3,132,586
-55,910
-2% -$4.45M 0.2% 100
2021
Q3
$239M Buy
3,188,496
+134,378
+4% +$10.2M 0.25% 85
2021
Q2
$235M Sell
3,054,118
-622,704
-17% -$46.3M 0.24% 85
2021
Q1
$270M Sell
3,676,822
-1,851,088
-33% -$137M 0.3% 72
2020
Q4
$431M Sell
5,527,910
-134,450
-2% -$10.3M 0.52% 41
2020
Q3
$448M Sell
5,662,360
-14,480
-0.3% -$1.13M 0.62% 35
2020
Q2
$419M Buy
5,676,840
+986,012
+21% +$74.2M 0.6% 35
2020
Q1
$344M Buy
4,690,828
+134,423
+3% +$10.6M 0.58% 32
2019
Q4
$395M Buy
4,556,405
+237,448
+5% +$19.5M 0.57% 35
2019
Q3
$347M Buy
4,318,957
+665,436
+18% +$53.3M 0.53% 37
2019
Q2
$292M Buy
3,653,521
+365,100
+11% +$28M 0.44% 45
2019
Q1
$261M Buy
3,288,421
+269,792
+9% +$20.2M 0.4% 46
2018
Q4
$220M Buy
3,018,629
+280,131
+10% +$19.8M 0.38% 47
2018
Q3
$185M Sell
2,738,498
-105,565
-4% -$6.73M 0.27% 66
2018
Q2
$165M Buy
2,844,063
+172,865
+6% +$9.75M 0.25% 84
2018
Q1
$139M Sell
2,671,198
-39,336
-1% -$2.12M 0.21% 89
2017
Q4
$146M Buy
2,710,534
+21,327
+0.8% +$1.18M 0.21% 84
2017
Q3
$164M Sell
2,689,207
-72,160
-3% -$4.37M 0.25% 74
2017
Q2
$169M Sell
2,761,367
-50,499
-2% -$3.07M 0.27% 76
2017
Q1
$170M Buy
2,811,866
+121,927
+5% +$7.4M 0.27% 77
2016
Q4
$151M Sell
2,689,939
-621,121
-19% -$36.4M 0.25% 80
2016
Q3
$197M Buy
3,311,060
+137,067
+4% +$8.02M 0.34% 56
2016
Q2
$174M Buy
3,173,993
+60,834
+2% +$3.24M 0.32% 63
2016
Q1
$157M Sell
3,113,159
-236,991
-7% -$11.6M 0.29% 67
2015
Q4
$169M Sell
3,350,150
-113,822
-3% -$5.74M 0.34% 58
2015
Q3
$163M Buy
3,463,972
+39,198
+1% +$2.08M 0.32% 58
2015
Q2
$186M Buy
3,424,774
+367,084
+12% +$20.6M 0.33% 59
2015
Q1
$168M Sell
3,057,690
-136,738
-4% -$7.74M 0.3% 59
2014
Q4
$173M Buy
3,194,428
+492,301
+18% +$27.4M 0.29% 64
2014
Q3
$153M Buy
2,702,127
+61,550
+2% +$3.46M 0.26% 68
2014
Q2
$146M Sell
2,640,577
-65,353
-2% -$3.57M 0.25% 71
2014
Q1
$147M Sell
2,705,930
-1,011,296
-27% -$52.4M 0.27% 64
2013
Q4
$178M Buy
3,717,226
+79,373
+2% +$3.63M 0.33% 54
2013
Q3
$165M Sell
3,637,853
-14,760
-0.4% -$674K 0.33% 56
2013
Q2
$162M Buy
+3,652,613
New +$163M 0.35% 54

Other funds holding MRK

TD Asset Management's MRK Position: Q1 2026 in Review

TD Asset Management increased its Merck (MRK) stake by 2.6% in Q1 2026, buying an estimated $6.67M and bringing the position to 2,288,576 shares worth $275M. The position accounts for 0.22% of the portfolio, ranked #85.

TD Asset Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $682M in Q1 2024. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • TD Asset Management held 2,288,576 shares of Merck worth $275M as of Q1 2026.
  • TD Asset Management bought 57,755 Merck shares in Q1 2026, an estimated $6.67M.
  • Merck made up 0.22% of TD Asset Management's portfolio in Q1 2026, its #85 holding.
  • TD Asset Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • TD Asset Management's Merck position peaked at $682M in Q1 2024.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on TD Asset Management's 13F filing for Q1 2026, filed 11 May 2026.